PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: andrea.lerner@nih.gov.\', \'Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: robert.eisinger@nih.gov.\', \'Office of the Director, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.\', \'Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521, USA.\', \'Biomedical Advanced Research and Development Authority, US Department of Health and Human Services, Washington, DC 20201, USA.\', \'Defense Advanced Research Projects Agency, US Department of Defense, Arlington, VA 22203, USA.\', \'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: CCassetti@niaid.nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1074-7613(20)30267-310.1016/j.immuni.2020.06.012
?:doi
?:hasPublicationType
?:journal
  • Immunity
is ?:pmid of
?:pmid
?:pmid
  • 32610080
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 13.393
?:rankingScore_hIndex
  • 342
?:title
  • The COVID-19 Serology Studies Workshop: Recommendations and Challenges.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32610080>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32610080>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all